{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:52:04Z","timestamp":1783633924646,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1989,3]]},"DOI":"10.1007\/bf01806528","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T23:38:26Z","timestamp":1119915506000},"page":"161-172","source":"Crossref","is-referenced-by-count":69,"title":["Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells"],"prefix":"10.1007","volume":"13","author":[{"given":"Richard","family":"Poulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernand","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01806528_CR1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01803566","volume":"3","author":"W Mattsson","year":"1983","unstructured":"Mattsson W: Current status of high dose progestin treatment in advanced breast cancer. Breast Cancer Res Treat 3: 231\u2013235, 1983","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl.","key":"BF01806528_CR2","first-page":"7","volume":"10","author":"GR Blumenschein","year":"1983","unstructured":"Blumenschein GR: The role of progestins in the treatment of breast cancer. Semin Oncol 10: 7\u201310, 1983 (suppl.)","journal-title":"Semin Oncol"},{"key":"BF01806528_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01806027","volume":"5","author":"GN Hortobagyi","year":"1985","unstructured":"Hortobagyi GN, Buzdar AU, Frye D, Yap HY, Hug V, Pinnamaneni K, Fraschini G, Halvorson HC, Blumenschein GR: Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer. Breast Cancer Res Treat 5: 321\u2013326, 1985","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl.","key":"BF01806528_CR4","first-page":"2","volume":"13","author":"DG Haller","year":"1986","unstructured":"Haller DG, Glick JH: Progestational agents in advanced breast cancer: an overview. Semin Oncol 13: 2\u20138, 1986 (suppl.)","journal-title":"Semin Oncol"},{"key":"BF01806528_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0022-4731(87)90339-6","volume":"27","author":"KB Horwitz","year":"1987","unstructured":"Horwitz KB: The structure and function of progesterone receptors in breast cancer. J Steroid Biochem 27: 447\u2013457, 1987","journal-title":"J Steroid Biochem"},{"issue":"suppl.","key":"BF01806528_CR6","first-page":"11","volume":"10","author":"ME Lippman","year":"1983","unstructured":"Lippman ME: Antiestrogen therapy of breast cancer. Semin Oncol 10: 11\u201319, 1983 (suppl.)","journal-title":"Semin Oncol"},{"key":"BF01806528_CR7","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0022-4731(83)90350-3","volume":"19","author":"G Perez-Palacios","year":"1983","unstructured":"Perez-Palacios G, Chavez B, Vilchis F, Escobar N, Larrea F, Perez AE: Interaction of medroxyprogesterone acetate with cytosol androgen receptors in the rat hypothalamus and pituitary. J Steroid Biochem 19: 1729\u20131735, 1983","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR8","first-page":"35S","volume":"36","author":"OA J\u00e4nne","year":"1984","unstructured":"J\u00e4nne OA, Bardin CW: Steroid receptors and hormone action: physiological and synthetic androgens and progestins can mediate inappropriate biological effects. Pharmacol Rev 36: 35S-42S, 1984","journal-title":"Pharmacol Rev"},{"key":"BF01806528_CR9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-4731(87)90095-1","volume":"26","author":"G Pridjian","year":"1987","unstructured":"Pridjian G, Schmit V, Schreiber J: Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells. J Steroid Biochem 26: 313\u2013319, 1987","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0022-4731(87)90317-7","volume":"27","author":"T Ojasoo","year":"1987","unstructured":"Ojasoo T, Delettr\u00e9 J, Mornon JP, Turpin-VanDycke C, Raynaud JP: Towards the mapping of the progesterone receptor. J Steroid Biochem 27: 255\u2013269, 1987","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR11","first-page":"2557","volume":"40","author":"FAG Teulings","year":"1980","unstructured":"Teulings FAG, van Gilse HA, Henkelman MS, Portengen H, Alexieva-Figusch J: Estrogen, androgen, glucocorticoid and progesterone receptors in progestin-induced regression of human breast cancer. Cancer Res 40: 2557\u20132561, 1980","journal-title":"Cancer Res"},{"key":"BF01806528_CR12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0002-9378(80)90911-4","volume":"137","author":"PCM Young","year":"1980","unstructured":"Young PCM, Keen FK, Einhorn LH, Stanick BM, Ehrlich CE, Cleary RE: Binding of medroxyprogesterone acetate in human breast cancer. Am J Obstet Gynecol 137: 284\u2013292, 1980","journal-title":"Am J Obstet Gynecol"},{"key":"BF01806528_CR13","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/endo-103-5-1768","volume":"103","author":"LP Bullock","year":"1978","unstructured":"Bullock LP, Bardin CW, Sherman MR: Androgenic, antiandrogenic and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors. Endocrinology 103: 1768\u20131782, 1978","journal-title":"Endocrinology"},{"key":"BF01806528_CR14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/1097-0142(19840915)54:1+<1208::AID-CNCR2820541319>3.0.CO;2-K","volume":"54","author":"HC Blossey","year":"1984","unstructured":"Blossey HC, Wander HE, Koebberling J, Nagel GA: Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer 54: 1208\u20131215, 1984","journal-title":"Cancer"},{"key":"BF01806528_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00257530","volume":"15","author":"H Veelen Van","year":"1985","unstructured":"Van Veelen H, Willemse PHB, Sleijfer DT, van der Ploeg E, Sluiter WJ, Doorenbos H: Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients. Cancer Chemother Pharmacol 15: 167\u2013170, 1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF01806528_CR16","first-page":"977","volume":"69","author":"H Veelen Van","year":"1985","unstructured":"Van Veelen H, Willemse PH, Sleijfer DT, Sluiter WJ, Doorenbos H: Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer. Cancer Treat Rep 69: 977\u2013983, 1985","journal-title":"Cancer Treat Rep"},{"key":"BF01806528_CR17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0015-0282(16)42864-5","volume":"28","author":"F Labrie","year":"1977","unstructured":"Labrie F, Ferland L, Lagac\u00e9 L, Drouin J, Asselin J, Azadian-Boulanger G, Raynaud JP: High inhibitory activity of R5020, a pure progestin, at the hypothalamic-adenohypophyseal level on gonadotropin secretion. Fertil Steril 28: 1104\u20131112, 1977","journal-title":"Fertil Steril"},{"key":"BF01806528_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-4731(81)90266-1","volume":"15","author":"G Perez-Palacios","year":"1981","unstructured":"Perez-Palacios G, Chavez B, Escobar N, Vilchis F, Larrea F, Lince M, Perez AE: Mechanism of action of contraceptive synthetic progestins. J Steroid Biochem 15: 125\u2013130, 1981","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR19","first-page":"327","volume":"3","author":"G Lelli","year":"1984","unstructured":"Lelli G, Angelleli B, Zanichelli L: The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patients. Chemiotherapia 3: 327\u2013329, 1984","journal-title":"Chemiotherapia"},{"key":"BF01806528_CR20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-4731(87)91054-5","volume":"28","author":"C Labrie","year":"1987","unstructured":"Labrie C, Cusan L, Plante M, Lapointe S, Labrie F: Analysis of the androgenic activity of synthetic \u2018progestins\u2019 currently used for the treatment of prostate cancer. J Steroid Biochem 28: 379\u2013384, 1987","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR21","first-page":"1","volume-title":"Role of Medroxyprogesterone in Endocrine-Related Tumors, Vol. 2","author":"S Iacobelli","year":"1983","unstructured":"Iacobelli S, Sica G, Natoli C, Gatti D: Inhibitory effects of medroxyprogesterone acetate on the proliferation of human breast cancer cells. In: Campio L, Robustelli Della Cuna G, Taylor CW (eds) Role of Medroxyprogesterone in Endocrine-Related Tumors, Vol. 2. Raven Press, New York, 1983, pp 1\u20136"},{"issue":"suppl.","key":"BF01806528_CR22","first-page":"3","volume":"12","author":"JC Allegra","year":"1985","unstructured":"Allegra JC, Kiefer SM: Mechanisms of action of progestational agents. Semin Oncol 12: 3\u20135, 1985 (suppl.)","journal-title":"Semin Oncol"},{"key":"BF01806528_CR23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(19840201)53:3+<630::AID-CNCR2820531308>3.0.CO;2-3","volume":"53","author":"JL Wittliff","year":"1984","unstructured":"Wittliff JL: Steroid-hormone receptors in breast cancer. Cancer 53: 630\u2013643, 1984","journal-title":"Cancer"},{"key":"BF01806528_CR24","first-page":"1447","volume":"39","author":"JC Allegra","year":"1979","unstructured":"Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken SC: Distribution, frequency and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 39: 1447\u20131454, 1979","journal-title":"Cancer Res"},{"key":"BF01806528_CR25","first-page":"2434","volume":"38","author":"KB Horwitz","year":"1978","unstructured":"Horwitz KB, Zava DT, Thilagar AK, Jensen EM, McGuire WL: Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res 38: 2434\u20132437, 1978","journal-title":"Cancer Res"},{"key":"BF01806528_CR26","first-page":"1","volume-title":"Steroids and Endometrial Cancer","author":"T Ojasoo","year":"1983","unstructured":"Ojasoo T, Raynaud JP: Receptor binding profiles of progestins. IN: Jasonni VM, Nenci I, Flamigni C (eds) Steroids and Endometrial Cancer. Raven Press, New York, 1983, pp 1\u201328"},{"key":"BF01806528_CR27","first-page":"3352","volume":"38","author":"LW Engel","year":"1978","unstructured":"Engel LW, Young NA, Trolka TS, Lippman ME, O'Brien SJ, Joyce MY: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38: 3352\u20133364, 1978","journal-title":"Cancer Res"},{"key":"BF01806528_CR28","first-page":"349","volume":"43","author":"P Darbre","year":"1983","unstructured":"Darbre P, Yates J, Curtis S, King RJB: Effect of estradiol on human breast cancer cells in culture. Cancer Res 43: 349\u2013354, 1983","journal-title":"Cancer Res"},{"key":"BF01806528_CR29","first-page":"4933","volume":"46","author":"R Poulin","year":"1986","unstructured":"Poulin R, Labrie F: Stimulation of cell proliferation and estrogenic response by adrenal C19\u2014D5 steroids in the ZR-75-1 human breast cancer cell line. Cancer Res 46: 4933\u20134937, 1986","journal-title":"Cancer Res"},{"key":"BF01806528_CR30","doi-asserted-by":"crossref","unstructured":"Poulin R, Baker D, Labrie F: Potent inhibition of basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12: 213\u2013225","DOI":"10.1007\/BF01805942"},{"key":"BF01806528_CR31","first-page":"2422","volume":"39","author":"CK Osborne","year":"1979","unstructured":"Osborne CK, Monaco ME, Kahn CR, Huff K, Bronzert D, Lippman ME: Direct inhibition of growth and antagonism by glucocorticoids in human breast cancer cells in culture. Cancer Res 39: 2422\u20132428, 1979","journal-title":"Cancer Res"},{"key":"BF01806528_CR32","unstructured":"Poulin R, Poirier D, Labrie F: Specific inhibition of cell proliferation by progestins and its antagonism by insulin in the ZR-75-1 human breast cancer cell line. 24th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA, 1988, Abstract 151"},{"key":"BF01806528_CR33","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1073\/pnas.83.8.2496","volume":"83","author":"Y Berthois","year":"1986","unstructured":"Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS: Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496\u20132500, 1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01806528_CR34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0022-4731(84)90347-9","volume":"20","author":"CM Taylor","year":"1984","unstructured":"Taylor CM, Blanchard B, Zava DT: A simple method to determine whole-cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture. J Steroid Biochem 20: 1083\u20131088, 1984","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR35","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1677\/joe.0.112R007","volume":"112","author":"AE Wakeling","year":"1987","unstructured":"Wakeling AE, Bowler J: Steroidal pure antiestrogens. J Endocrinol 112: R7-R10, 1987","journal-title":"J Endocrinol"},{"key":"BF01806528_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-4731(85)90401-7","volume":"23","author":"D Gagn\u00e9","year":"1985","unstructured":"Gagn\u00e9 D, Pons M, Philibert D: RU38486: a potent antiglucocorticoidin vitro andin vivo. J Steroid Biochem 23: 247\u2013251, 1985","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR37","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1210\/endo-116-6-2236","volume":"116","author":"KB Horwitz","year":"1985","unstructured":"Horwitz KB: The antiprogestin RU38486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells. Endocrinology 116: 2236\u20132245, 1985","journal-title":"Endocrinology"},{"key":"BF01806528_CR38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0022-4731(86)90313-4","volume":"25","author":"JP Raynaud","year":"1986","unstructured":"Raynaud JP, Ojasoo T: The design and use of sex-steroid antagonists. J Steroid Biochem 25: 811\u2013833, 1986","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","volume":"44","author":"J Simard","year":"1986","unstructured":"Simard J, Luthy I, Guay J, B\u00e9langer A, Labrie F: Characteristics of the interaction of the antiandrogen Flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 44: 261\u2013270, 1986","journal-title":"Mol Cell Endocrinol"},{"key":"BF01806528_CR40","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/endo-94-5-1427","volume":"94","author":"D Rodbard","year":"1974","unstructured":"Rodbard D: Apparent cooperative effect in cyclic AMP and corticosterone production by isolated adrenal cells in response to ACTH analogues. Endocrinology 94: 1427\u20131437, 1974","journal-title":"Endocrinology"},{"key":"BF01806528_CR41","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH: Relationship between the inhibition constant (Ki) and the concentration of inhibition which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099\u20133108, 1973","journal-title":"Biochem Pharmacol"},{"key":"BF01806528_CR42","first-page":"77","volume-title":"Adrenal Steroid Antagonism","author":"D Philibert","year":"1984","unstructured":"Philibert D: RU38486: an original multifaceted antihormonein vivo. In: Agarwal MK (ed) Adrenal Steroid Antagonism. Walter de Guyter, Berlin (1984) pp 77\u2013101"},{"key":"BF01806528_CR43","doi-asserted-by":"crossref","unstructured":"Poulin R: Androgens suppress immunologically detectable estrogen and progesterone receptors in ZR-75-1 human breast cancer cells. 70th Annual Meeting of the Endocrine Society, New Orleans, LA, (Abstract), p 347, 1988","DOI":"10.1016\/0022-4731(87)91555-X"},{"key":"BF01806528_CR44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01806133","volume":"10","author":"PG Gill","year":"1987","unstructured":"Gill PG, Vignon F, Bardon S, Derocq D, Rochefort H: Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells. Breast Cancer Res Treat 10: 37\u201345, 1987","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806528_CR45","first-page":"673","volume":"69","author":"MM Ip","year":"1982","unstructured":"Ip MM, Milholland RJ, Kim U, Rosen F: Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumors in the rat. J Natl Cancer Inst 69: 673\u2013681, 1982","journal-title":"J Natl Cancer Inst"},{"key":"BF01806528_CR46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jcem-53-4-836","volume":"53","author":"JH MacIndoe","year":"1981","unstructured":"MacIndoe JH, Etre LA: An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab 53: 836\u2013842, 1981","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806528_CR47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/mend-2-1-62","volume":"2","author":"LL Wei","year":"1988","unstructured":"Wei LL, Krett NL, Francis MD, Gordon DF, Wood WM, O'Malley BW, Horwitz KB: Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells. Mol Endocrinol 2: 62\u201372, 1988","journal-title":"Mol Endocrinol"},{"key":"BF01806528_CR48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1210\/mend-2-3-263","volume":"2","author":"LD Read","year":"1988","unstructured":"Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS: Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 2: 263\u2013271, 1988","journal-title":"Mol Endocrinol"},{"key":"BF01806528_CR49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/B978-0-12-452809-3.50016-6","volume-title":"Biochemical Actions of Hormones, Vol. IX","author":"JP Raynaud","year":"1982","unstructured":"Raynaud JP, Ojasoo T, Pottier J: Chemical substitution of steroid hormones: effect on receptor binding and pharmacokinetics. In: Litwack G (ed) Biochemical Actions of Hormones, Vol. IX. Academic Press, New York, 1982, pp. 305\u2013342"},{"key":"BF01806528_CR50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0022-4731(81)90293-4","volume":"15","author":"M Moguilewsky","year":"1981","unstructured":"Moguilewsky M, Deraedt R: Interrelations between glucocorticoid and progestin receptors. J Steroid Biochem 15: 329\u2013335, 1981","journal-title":"J Steroid Biochem"},{"key":"BF01806528_CR51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1677\/joe.0.1030287","volume":"103","author":"F Carlo Di","year":"1984","unstructured":"Di Carlo F, Racca S, Conti G, Gallo E, Muccioli G, Sapino A, Bussolati G: Effects of long-term administration of high doses of medroxyprogesterone acetate on hormone receptors and target organs on the female rat. J Endocrinol 103: 287\u2013293, 1984","journal-title":"J Endocrinol"},{"key":"BF01806528_CR52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-349-81345-2_11","volume-title":"Mechanisms of Steroid Action","author":"JP Raynaud","year":"1981","unstructured":"Raynaud JP, Ojasoo T, Labrie F: Steroid hormones-agonists and antagonists. In: Lewis GP, Ginsburg M (eds) Mechanisms of Steroid Action. MacMillan Press, London, 1981, pp 145\u2013158"},{"key":"BF01806528_CR53","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/endo-107-5-1393","volume":"107","author":"GP Guthrie","year":"1980","unstructured":"Guthrie GP, John WJ: Thein vivo glucocorticoid and antiglucocorticoid actions of medroxyprogesterone acetate. Endocrinology 107: 1393\u20131396, 1980","journal-title":"Endocrinology"},{"key":"BF01806528_CR54","first-page":"2","volume":"10","author":"WL McGuire","year":"1983","unstructured":"McGuire WL, Clark GM: The prognostic role of progesterone receptors in human breast cancer. Semin Oncol 10: 2\u20136, 1983","journal-title":"Semin Oncol"},{"key":"BF01806528_CR55","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H","volume":"54","author":"RM Bryan","year":"1984","unstructured":"Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer 54: 2436\u20132440, 1984","journal-title":"Cancer"},{"key":"BF01806528_CR56","first-page":"167","volume":"45","author":"KB Horwitz","year":"1985","unstructured":"Horwitz KB, Freidenberg GR: Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47Dco human breast cancer cells by progestins: implications for endocrine therapies. Cancer Res 45: 167\u2013173, 1985","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806528\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:06:54Z","timestamp":1586304414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,3]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,3]]}},"alternative-id":["BF01806528"],"URL":"https:\/\/doi.org\/10.1007\/bf01806528","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,3]]}}}